25 March 2025 - ViiV Healthcare is pleased to announce that Apretude (cabotegravir tablets and extended release injectable suspension) is ...
21 March 2025 - In Canada, one in 12 people live with a rare disease, and for most people affected, the ...
28 February 2025 - On Rare Disease Day — a global event dedicated to raising awareness for the millions of ...
28 February 2025 - Positive CDA and INESSS reimbursement recommendations are an important step towards public access to Bimzelx, the first ...
27 February 2025 - Additional agreement will improve access and affordability of drugs for rare diseases. ...
13 February 2025 - ViiV Healthcare is pleased to announce it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance ...
24 January 2025 - Today, the Governments of Canada and the province of Ontario signed the National Strategy for Drugs ...
9 January 2025 - Recommendations will help organisations that appraise new drugs establish whether their use will result in longer-term ...
18 October 2024 - One step closer to achieving public reimbursement of Amvuttra for hereditary transthyretin-mediated amyloidosis. patients in Canada ...
5 December 2024 - Today, the Honourable Mark Holland, Canada's Minister of Health, and the Honourable Adriana LaGrange, Alberta's Minister ...
28 November 2024 - Canada’s Drug Agency is launching a consultation on its first ever methods guide. ...
19 November 2024 - Eli Lilly Canada is disappointed and strongly disagrees with Canada's Drug Agency (CDA-AMC)'s Final Recommendation for Ebglyss ...
8 November 2024 - Merck announced that Canada's Drug Agency has recommended Winrevair (sotatercept) for reimbursement in combination with standard ...
3 November 2024 - Officials say there is no universally available, publicly funded RSV vaccine program for newborns in Nova Scotia. ...
31 October 2024 - In this cross-sectional study, there were 104 reports of drug-related supply chain issues that occurred from 2017 ...